BEYOND THE FIRST FILL

BEYOND THE FIRST FILL

HOW 5 NCODA PRACTICES WERE EMPOWERED TO TAKE THE NEXT STEP IN IMPROVING PATIENT CARE   By Bill Wimbiscus Oncolytics Today Editor There’s a moment in the life of nearly every oral oncology patient, a moment that can have a profound effect on their treatment outcome.  ...
BIRTH OF AN ORAL ONCOLYTIC

BIRTH OF AN ORAL ONCOLYTIC

THE QUEST FOR A NEW CANCER DRUG IS NOT FOR THE FAINT OF HEART  By  Brett Williams, PhD  With 10 new FDA approvals in the second half of 2019 alone, the toolbox of oral oncolytics is continuously expanding.   These new approvals present patients and providers alike...
THE UNDERLYING BIAS OF PHARMACOGENOMICS 

THE UNDERLYING BIAS OF PHARMACOGENOMICS 

RACIAL EXCLUSION IN CANCER CLINICAL TRIALS HAS LEFT BEHIND THE POPULATIONS MOST IN NEED OF TREATMENT  By Porscha Johnson, PharmD, CPGx  While research has led to profound advancements in cancer treatments — including antibody-drug conjugates and immunotherapy, as well...